2-[(3-Chlorophenyl)methyl]-1H,2H,3H-pyrrolo[3,4-c]pyridine-1,3-dione

Catalog No. :
ACRCRG306
CAS No. :
339098-53-2
Molecular Formula :
C14H9ClN2O2
Molecular Weight :
272.69

IUPAC Name:2-(3-chlorobenzyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione

2-[(3-Chlorophenyl)methyl]-1H,2H,3H-pyrrolo[3,4-c]pyridine-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$286.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[(3-Chlorophenyl)methyl]-1H,2H,3H-pyrrolo[3,4-c]pyridine-1,3-dione
IUPAC Name2-(3-chlorobenzyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione
MDL No.MFCD01443785
Molecular FormulaC14H9ClN2O2
Molecular Weight272.69
SMILESO=C1N(CC2=CC=CC(Cl)=C2)C(C3=C1C=CN=C3)=O
InChI KeyVTUDBWWETXFLLG-UHFFFAOYSA-N
Synonym2-(3-CHLOROBENZYL)-1H-PYRROLO[3,4-C]PYRIDINE-1,3(2H)-DIONE;2-[(3-chlorophenyl)methyl]-1H,2H,3H-pyrrolo[3,4-c]pyridine-1,3-dione;1H-Pyrrolo[3,4-c]pyridine-1,3(2H)-dione, 2-[(3-chlorophenyl)methyl]-
CAS No.339098-53-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRCRG306 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNYXS531 route compound structure diagram
    ACNYXS5314664-01-1 In Stock
  4. Then
  5. ACRCRG306 route product structure diagram
    ACRCRG306339098-53-2
Inquiry

2. ACRCRG306 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNYXS531 route compound structure diagram
    ACNYXS5314664-01-1 In Stock
  4. Then
  5. ACRCRG306 route product structure diagram
    ACRCRG306339098-53-2
Inquiry

Comments (0)